论文部分内容阅读
我们从1996年到1997年应用德国威玛舒博士药厂生产的银杏叶提取物金纳多(EGB)针剂治疗急性脑梗塞32例,取得了较好的疗效,降低了致残率,现将结果报告如下.1 资料与方法1.1 临床资料 本组共64例患者,均按1986年第二次全国脑血管病学术会议第三次修订的脑梗塞诊断标准,均经头颅CT或MRT扫描证实,并有明显的神经功能缺损的定位体征.随机分为治疗组和对照组,每组各32例.对照组,男16例,女16例,年龄53至70平均58.1岁;治疗组,男18例,女14例,年龄52至67岁平均59.1岁.两组患者病情程度、发病和开始给药时间基本相同,其既往史和并发症评分,经计算其平均积分相近,说明两组患者具有可比性.
From 1996 to 1997, we applied the Ginkgo biloba extract (GGB) produced by Germany Weimashu Pharmaceutical Factory to treat 32 cases of acute cerebral infarction, and achieved good curative effect and reduced morbidity. The results are reported as follows.1 Materials and Methods 1.1 Clinical data 64 patients in this group, according to the second national cerebrovascular disease conference in 1986 the third revision of the diagnostic criteria for cerebral infarction, were confirmed by head CT or MRT scan, And there are obvious signs of neurological deficit.All patients were randomly divided into treatment group and control group, 32 cases in each group.Control group, 16 males and 16 females, aged 53 to 70 average 58.1 years; treatment group, male 18 Cases, 14 females, aged 52 to 67 years old average 59.1 years old.The two groups of patients with the same level of illness, onset and start of administration, its past history and complication scores, calculated by the average integral similar to the two groups of patients with Comparability.